Covid-19 Archives - SAHPRA

Update on COVID-19 vaccines

Thu, 26 Oct 2023 11:13:37 +0000

Pretoria, 26 October 2023 – The South African Health Products Regulatory Authority (SAHPRA) currently has four (4) COVID-19 vaccines which are under review, the COMIRNATY Bivalent paediatric and adult vaccines, mRNA (COMIRNATY Bivalent Infant DTU vaccine), and non-mRNA vaccine Coviccine. SAHPRA has so far registered...

The post Update on COVID-19 vaccines appeared first on SAHPRA.

]]>

ICMRA statement on the safety of COVID-19 vaccines

Fri, 07 Jul 2023 06:08:35 +0000

The South Africa Health Products Regulatory Authority (SAHPRA), in collaboration with Pharmacometrics Africa and tThe Department of Pharmacy and Pharmacology at the University of Witwatersrand, is pleased to announce the second cohort of graduates who successfully completed the short course for Clinical Assessors within African Regulatory Agencies.

The post ICMRA statement on the safety of COVID-19 vaccines appeared first on SAHPRA.

]]>

SAHPRA perspectives on Coronavirus SARS-COV-2

Mon, 15 May 2023 19:59:26 +0000

Pretoria, 15 May 2023 -The South Africa Health Products Regulatory Authority (SAHPRA) acknowledges and aligns itself to the statement issued by the World Health Organization (WHO) Director-General, declaring an end to the Public Health Emergency of International Concern (PHEIC) for the disease caused by the...

The post SAHPRA perspectives on Coronavirus SARS-COV-2 appeared first on SAHPRA.

]]>

SAHPRA registers Paxlovid, an anti-viral medicine for COVID-19

Mon, 30 Jan 2023 16:24:44 +0000

Pretoria, 30 January 2023 – The South African Health Products Regulatory Authority (SAHPRA) has registered Paxlovid, an anti-viral medicine manufactured by Pfizer, to treat COVID-19. Paxlovid, which contains Nirmatrelvir (150mg) and Ritonavir (100mg), is a medicine that is used for the treatment of mild to...

The post SAHPRA registers Paxlovid, an anti-viral medicine for COVID-19 appeared first on SAHPRA.

]]>

SAHPRA approves antigen self-test kits for public use

Thu, 24 Nov 2022 16:31:48 +0000

Pretoria, 24 November 2022 – In the past year, the South African Health Products Regulatory Authority (SAHPRA) approved the antigen test kits for use by healthcare professionals. SAHPRA has now approved seven (7) COVID-19 antigen self-test kits that can be used as self-test/ at home...

The post SAHPRA approves antigen self-test kits for public use appeared first on SAHPRA.

]]>

SAHPRA registers COMIRNATY’s paediatric and adult vaccines

Tue, 22 Nov 2022 13:35:00 +0000

22 November 2022 Embargo: Immediate release Pretoria, 22 November 2022 – The South African Health Products Regulatory Authority (SAHPRA) has registered Pfizer’s COMIRNATY Ready To Use (RTU) ADULT VACCINE and Dilute To Use (DTU) PAEDIATRIC VACCINE on 15 November 2022. The RTU vaccine, as the...

The post SAHPRA registers COMIRNATY’s paediatric and adult vaccines appeared first on SAHPRA.

]]>

SAHPRA registers the COVID-19 vaccine, Coronavac

Fri, 24 Jun 2022 13:24:30 +0000

Embargo: Immediate release Pretoria, 24 June 2022 – The South African Health Products and Regulatory Authority (SAHPRA) registered the COVID-19 vaccine, Coronavac, on 14 June 2022, with conditions. The registration was done in terms of Section 15(6a) of the Medicines and Related Substance Act 101...

The post SAHPRA registers the COVID-19 vaccine, Coronavac appeared first on SAHPRA.

]]>

The Dynamics of Assuming a New CEO or Leadership Role under Global Lockdown Restrictions

Fri, 17 Jun 2022 11:18:27 +0000

17 June 2022 CEO Perspectives and Horizons as Covid-19 takes a grip The SAHPRA CEO, Dr Boitumelo Semete-Makokotlela shares her journey since she assumed the position of CEO. She unpacks how she had to face a “sink or swim” situation as the COVID-19 pandemic gripped...

The post The Dynamics of Assuming a New CEO or Leadership Role under Global Lockdown Restrictions appeared first on SAHPRA.

]]>

SAHPRA registers a vaccine and provides emergency use authorisation of health products in the fight against COVID-19

Tue, 07 Jun 2022 11:22:03 +0000

07 June 2022 Embargo: Immediate release1. The COVID-19 vaccine LHC has been registered with conditions on 24 May 2022.The registration of the COVID-19 vaccine LHC was done in terms of Section 15(6a) of the Medicines and Related Substance Act 101 of 1965. This COVID-19 vaccine...

The post SAHPRA registers a vaccine and provides emergency use authorisation of health products in the fight against COVID-19 appeared first on SAHPRA.

]]>

SAHPRA Comments on ACDP court matter on vaccines for minors

Tue, 03 May 2022 21:42:35 +0000

03 May 2022 Embargo: Immediate release Pretoria, 3 May 2022 – In October 2021, the African Christian Democratic Party (ACDP); Free the Children -Save the Nation NPC, Caring Healthcare Workers Coalition NPC, and the COVID Care Alliance NPC initiated court action against the Minister of...

The post SAHPRA Comments on ACDP court matter on vaccines for minors appeared first on SAHPRA.

]]>